Trials / Completed
CompletedNCT04389554
D-dimer Levels in Pregnant With COVID-19
Assessment of D-dimer Levels in Pregnant Women Diagnosed With COVID-19
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (actual)
- Sponsor
- Kanuni Sultan Suleyman Training and Research Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- —
Summary
D-dimer measurements act as a global indicator of coagulation and activation of fibrinolytic systems. An optimal cut-off value for D-dimer and its effect on prognosis has not yet been assessed to predict mortality in admission. Therefore, studies comparing D-dimer values of COVID-19 patients and healthy pregnant women are needed. Our study gives us the opportunity to make this comparison.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood D-dimer assay | Blood samples will be taken from the patients and will be examined by the ELISA method. |
Timeline
- Start date
- 2020-05-14
- Primary completion
- 2020-05-28
- Completion
- 2020-05-29
- First posted
- 2020-05-15
- Last updated
- 2020-06-01
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT04389554. Inclusion in this directory is not an endorsement.